BASF debuts white biotech research lab in USA

Germany-headquartered BASF (BAS: DE), the world’s biggest chemical company, has opened a new white biotechnology and microbiology research center in Tarrytown, New York, USA. In the laboratory, biologists and biotechnologists will work to develop more efficient biotechnological production processes and - together with material researchers - develop new antimicrobial products for medical technology, hygiene and health care.

“The investment again demonstrates BASF’s commitment to white biotechnology, one of this century’s key technologies with vast potential for innovation. Furthermore the new lab is an important step on the way to an even more globally organized research, and a very good base for successful new alliances in North America,” said Harald Lauke, head of Biological & Effect Systems Research.

BASF has more than three decades of experience in white biotechnology. The company uses biotechnological methods to produce products such as vitamins, enzymes, pharmaceutical intermediates and specialties for the personal care, food and feed industries. One focus of the research laboratory work is to develop even more efficient and resource-conserving production processes. The use of metabolic engineering – the targeted modification of metabolism – is set to enhance the efficiency of the microorganisms used in these production processes.